Skip to content
JAMA Dermatology Author Interviews cover art

All Episodes

JAMA Dermatology Author Interviews — 132 episodes · page 1 of 2

#
Title
1

Melanoma Prevention Among Children of Melanoma Survivors

2

Longitudinal Growth in Children with Epidermal Differentiation Disorders

3

Consumer Understanding of Skin Concerns With an AI-Powered Informational Tool

4

A Pigment-Informed Dermatology Framework—Reimagining "Skin of Color"

5

Sunscreen Costs in Association With Sun Protective Behaviors

6

Discordance in Treatment Response Assessment Between Clinicians and Patients With Skin Chronic GVHD

7

Advanced Practice Clinicians and Dermatology Drug Spending

8

Recovering From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

9

Skin Cancer Surveillance Program for Solid Organ Transplant Recipients

10

Nicotinamide for Skin Cancer Chemoprevention

11

A Risk Prediction Tool for Invasive Melanoma

12

Emollients to Prevent Pediatric Eczema

13

Defining On-Treatment Remission in Plaque Psoriasis

14

How to Publish a Research Paper in a High-Impact Dermatology Journal—A Primer for Trainees

15

Use of and Cost of First-Line Biologics to Treat Plaque Psoriasis in the US

16

3D Total-Body Photography in Patients at High Risk for Melanoma

17

The Role of Formulation in Benzene Formation in Benzoyl Peroxide Products

18

Superficial Curettage Plus Imiquimod Cream for Nodular Basal Cell Carcinoma

19

Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age

20

Hidradenitis Suppurativa and Maternal and Offspring Outcomes

21

Global Antimicrobial Susceptibility Patterns of Staphylococcus aureus in Atopic Dermatitis

22

Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis

23

Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1

24

Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma

25

Single-Lesion Skin Cancer Risk Stratification Triage Pathway

26

Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae

27

Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders

28

Symptoms of Cognitive Impairment Among Children With Atopic Dermatitis

29

Efficacy and Durability of Intravenous Ertapenem Therapy for Recalcitrant Hidradenitis Suppurativa

30

Lived Experience of Acne and Acne Treatment in Transgender Patients

31

Pathologist Characteristics and Higher-Grade Diagnoses for Melanocytic Lesions

32

Patient Perspectives on Social Risk Screening and Documentation

33

Alopecia Areata Treatment Patterns

34

Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma

35

Risk of Mortality After a Diagnosis of Melanoma In Situ

36

A Skin-Directed Scoring System for Epidermal Necrolysis

37

Publication Trends of Qualitative Research in Dermatology

38

AI Support Tool for Telemedicine

39

Double Standards and Inconsistencies in Access to Dermatologic Care

40

Automating Hair Loss Labels for Universally Scoring Alopecia From Images

41

Diversity and Goals of Graduating Medical Students Pursuing Careers in Dermatology

42

Dermatologic Follow-up vs Emergency Department Return Among Patients With Hidradenitis Suppurativa

43

Dermatology Societies Should Explore Fossil Fuel Divestment

44

Effect of Prior Diagnoses on Dermatopathologists' Interpretations of Melanocytic Lesions

45

Projective Personification Approach to the Experience of People With Acne and Acne Scarring

46

A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief

47

Ode to Kodachrome

48

Hair and Black−White Race Relations in the US

49

Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System

50

Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients

51

Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis

52

Patient Impressions and Outcomes Following Clinic to Based Hidradenitis Suppurativa Surgery

53

Drug Survival of Biologics in Patients With Hidradenitis Suppurativa

54

Association Between Atopic Dermatitis and Height, Body Mass Index, and Weight in Children

55

Risks of Multiple Skin Cancers in Organ Transplant Recipients

56

Lack of Transparency and Potential Bias in AI Data Sets and Algorithms

57

Differences Between Children and Adults With Hidradenitis Suppurativa

58

Patient Perspectives on the Lived Experience of Acne Among Adult Women

59

Trends of Research Output in Allopathic Medical Students Matching Into Dermatology, 2007-2018

60

Long-term Physical and Psychological Outcomes of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

61

Association Between Atopic Dermatitis and Educational Attainment in Denmark

62

Detection of New Primary Melanoma in High-risk Clinics for Skin Surveillance

63

The Role of Dermatologists in the Early HIV/AIDS Epidemic

64

Association of Topical Corticosteroids and Risk of Osteoporosis and Major Osteoporotic Fractures

65

UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color

66

Cost Minimization Analysis of a Teledermatology Triage System in a Managed Care Setting

67

Multiple vs First Incidence of Cutaneous Squamous Cell Carcinoma and Estimation of Future Incidences

68

Indoor Tanning 5 Years After Youth Access Restrictions

69

Administrative Burden and Costs of Prior Authorizations in a Dermatology Department

70

Prognostic Gene Expression Profiling in Cutaneous Melanoma

71

Dermatologic Care in Oncology and Patterns of Prophylaxis for EGFRi-Associated Skin Toxicity

72

Face-Aging Mobile App–Based Intervention on Skin Cancer Protection Behavior

73

Changes in Disease Activity and Damage Over Time in Patients With Morphea

74

Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening

75

Association Between Sexual Orientation and Lifetime Prevalence of Skin Cancer in the United States

76

100th Anniversary of JAMA Dermatology as a Publication of the American Medical Association

77

Effect of Topical Brimonidine on Alcohol-Induced Flushing in Asian Individuals

78

Age-Specific Incidence of Melanoma in the United States

79

Factors Associated With Complete Remission After Rituximab Therapy for Pemphigus

80

Natural Does Not Mean Safe

81

Assessment of Black Patients' Perception of Their Dermatology Care

82

Trends in Private Equity Acquisition of US Dermatology Practices

83

Barriers to Telehealth Programs and Dermatological Care for American Indian Communities

84

Patients' Views About Self-examination After Treatment for Localized Melanoma

85

Comparative Overall Comorbidity Burden Among Patients With Hidradenitis Suppurativa

86

Assessment of Sleep and Exhaustion in Mothers of Children With Atopic Dermatitis

87

Development and Validation of a Risk-Prediction Model for in-Hospital Mortality of Patients With SJS/TEN

88

Trends in Oral Antibiotic Prescription in Dermatology, 2008 to 2016

89

Milestone Clinical Events in Patients From North America With Epidermolysis Bullosa

90

Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab vs Ipilimumab Alone for Unresectable Melanoma

91

Risk of Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Margins

92

Differences in Use of Outpatient Dermatology Services in the United States

93

Association of Inadequately Controlled Disease With Patient-reported Disease Burden in Atopic Dermatitis

94

Topical Rapamycin in Patients With Facial Angiofibromas

95

Review of Sun Protection in Adults and Children

96

Fluorouracil for Prevention of Keratinocyte Carcinoma

97

Association of Delays in Surgery for Melanoma With Insurance Type

98

Psoriasis

99

Perineural Invasion of Cutaneous Squamous Cell Carcinoma

100

Cutaneous T-Cell Lymphomas